ResearcherKyoto UniversityActive in the last 2 years
Kozo Ikuta
Matched on OpenAlex author ID A5107174724. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. Co-author DOI 10.1038/s41416-024-02794-5↗
- Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. Co-author DOI 10.7554/elife.55117↗
- Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. Co-author DOI 10.1136/gutjnl-2017-315425↗
- ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice. Co-author DOI 10.1053/j.gastro.2018.03.039↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Takahisa Maruno · 4 shared papers, 2018–2024 · strength 0.38
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Paper Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. DOI 10.7554/elife.55117↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Hiroshi Seno · 4 shared papers, 2018–2024 · strength 0.38
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Paper Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. DOI 10.7554/elife.55117↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Akihisa Fukuda · 4 shared papers, 2018–2024 · strength 0.38
- Paper Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. DOI 10.1038/s41416-024-02794-5↗
- Paper Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. DOI 10.7554/elife.55117↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Tsutomu Chiba · 3 shared papers, 2018–2021 · strength 0.25
- Paper Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. DOI 10.7554/elife.55117↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Paper ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinom… DOI 10.1053/j.gastro.2018.03.039↗
- Shinji Üemoto · 3 shared papers, 2018–2021 · strength 0.25
- Paper Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. DOI 10.7554/elife.55117↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Paper ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinom… DOI 10.1053/j.gastro.2018.03.039↗
- Motoyuki Tsuda · 3 shared papers, 2018–2021 · strength 0.25
- Paper Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. DOI 10.7554/elife.55117↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Paper ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinom… DOI 10.1053/j.gastro.2018.03.039↗
- Satoshi Ogawa · 3 shared papers, 2018–2021 · strength 0.25
- Paper Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. DOI 10.7554/elife.55117↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Paper ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinom… DOI 10.1053/j.gastro.2018.03.039↗
- Kyoichi Takaori · 3 shared papers, 2018–2021 · strength 0.25
- Paper Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. DOI 10.7554/elife.55117↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Paper ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinom… DOI 10.1053/j.gastro.2018.03.039↗
- Yoshito Kimura · 2 shared papers, 2018–2019 · strength 0.14
- Toshinao Itani · 1 shared paper, 2024 · strength 0.13
- Nobuhiro Hieda · 1 shared paper, 2024 · strength 0.13
- Kosuke Minaga · 1 shared paper, 2024 · strength 0.13
- Munenori Kawai · 1 shared paper, 2024 · strength 0.13
- Toshihiro Morita · 1 shared paper, 2024 · strength 0.13
- Yukitaka Yamashita · 1 shared paper, 2024 · strength 0.13
- Atsushi Umemura · 1 shared paper, 2024 · strength 0.13
- Makoto Sono · 1 shared paper, 2024 · strength 0.13
- Shujiro Yazumi · 1 shared paper, 2024 · strength 0.13
- Masaya Ohana · 1 shared paper, 2024 · strength 0.13
- Masatoshi Kudo · 1 shared paper, 2024 · strength 0.13
- Dieter Saur · 1 shared paper, 2021 · strength 0.11
- Kenji Masuo · 1 shared paper, 2019 · strength 0.07
- Yuto Kimura · 1 shared paper, 2019 · strength 0.07
- Shigeo Takaishi · 1 shared paper, 2019 · strength 0.07
- Osamu Araki · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.